BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• FDA

  FDA Approves Ultragenyx’s Treatment for Rare Genetic Enzyme Disorder

  The FDA today approved Mepsevii to treat pediatric and adult patients with an inherited metabolic condition called MPS VII, also known as Sly syndrome.

  November 15, 2017

   · 

  3 min read
• Oncodesign Announces Positive Results Opening the Way for The ALK1 Program to Advance to the Lead Optimization Phase

  The company has obtained positive results opening the way for the ALK1 kinase inhibitor discovery program to move on to the lead optimization phase.

  November 15, 2017

   · 

  4 min read
• Policy

  3Shape Responds to Align Technology Patent Infringement Lawsuit

  3Shape says the lawsuit and infringement claims are completely unfounded and without merit. 3Shape will vigorously defend itself against such claims.

  November 15, 2017

   · 

  2 min read
• Aquila Diagnostic Systems Releases Independent Trial Results for Its AccutasVET Tapeworm Fecal Test

  The study demonstrated that the diagnostic performance characteristics of the AccutasVET Tapeworm fecal test are clinically significant and exceed the diagnostic performance of current practices and currently available in-clinic tapeworm test kits.

  November 15, 2017

   · 

  2 min read
• BioCapital

  FDA unveils a streamlined path for the authorization of tumor profiling tests alongside its latest product action

  The IMPACT test uses NGS to rapidly identify the presence of mutations in 468 unique genes, as well as other molecular changes in the genomic makeup of a person’s tumor.

  November 15, 2017

   · 

  5 min read
• Business

  Sales of Olainfarm in October Shrink by 7%

  Preliminary consolidated results of AS Olainfarm for October 2017 show that company’s sales have reached 9.51 million euros, which represents reduction by 7% compared to the same period of 2016.

  November 15, 2017

   · 

  4 min read
• Business

  Tempus Announces Latest Immunotherapy Project

  The company announced a new research collaboration aimed at identifying which patients will respond positively to immunotherapy treatment, the next generation of cancer care.

  November 15, 2017

   · 

  4 min read
• Biotech Bay

  CSSi LifeSciences Release: Jim Sergi Invited to Serve as Moderator for 2017 World Alliance Forum in San Francisco

  Mr. Sergi will moderate the panel discussion titled, “Cancer Moonshot.”

  November 15, 2017

   · 

  2 min read
• Business

  Scott VanderWel Joins PCI Synthesis as Business Development Manager

  VanderWel will lead sales and marketing efforts for the West Coast.

  November 15, 2017

   · 

  2 min read
• Business

  Elizabeth Iorns, Ph.D., CEO of Science Exchange Elected to the Board of Directors of the Drug, Chemical & Associated Technologies Association (DCAT)

  Science Exchange announced today that Elizabeth Iorns, Ph.D., CEO of Science Exchange, has been elected to serve her first term on the Board of DCAT beginning November 1, 2017.

  November 15, 2017

   · 

  2 min read